Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world.

We teamed up with Medikidz and the COPD Foundation to develop a creative way to explain COPD to children.

Novartis BioCamp gives students new perspectives on healthcare challenges.

Novartis is supporting World Cancer Day by reimagining cancer in the workplace through a dedicated global program.